• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫球蛋白治疗传染性疾病。

Hyperimmune Globulins for the Management of Infectious Diseases.

机构信息

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

出版信息

Viruses. 2023 Jul 13;15(7):1543. doi: 10.3390/v15071543.

DOI:10.3390/v15071543
PMID:37515229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10385259/
Abstract

This review is focused on the use of hyperimmune globulin therapy to treat some infectious diseases of viral or bacterial origin. Despite the introduction of antibiotics and vaccines, plasma immunoglobulin therapy from whole blood donation can still play a key role. These treatments provide passive transfer of high-titer antibodies that either reduces the risk or the severity of the infection and offer immediate but short-term protection against specific diseases. Antibody preparations derived from immunized human donors are commonly used for the prophylaxis and treatment of rabies, hepatitis A and B viruses, varicella-zoster virus, and pneumonia caused by respiratory syncytial virus, , . The use of hyperimmune globulin therapy is a promising challenge, especially for the treatment of emerging viral infections for which there are no specific therapies or licensed vaccines.

摘要

这篇综述主要关注的是使用免疫球蛋白疗法来治疗一些病毒性或细菌性传染病。尽管抗生素和疫苗已经问世,但来自全血捐献的血浆免疫球蛋白疗法仍能发挥关键作用。这些治疗方法提供了高滴度抗体的被动转移,从而降低了感染的风险或严重程度,并对特定疾病提供了即时但短期的保护。从免疫供体中获得的抗体制剂通常用于预防和治疗狂犬病、甲型和乙型肝炎病毒、水痘-带状疱疹病毒以及由呼吸道合胞病毒引起的肺炎,。免疫球蛋白疗法的应用是一个有前途的挑战,特别是对于治疗新兴的病毒感染,这些感染目前没有特定的治疗方法或许可的疫苗。

相似文献

1
Hyperimmune Globulins for the Management of Infectious Diseases.免疫球蛋白治疗传染性疾病。
Viruses. 2023 Jul 13;15(7):1543. doi: 10.3390/v15071543.
2
Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases.多克隆免疫球蛋白和高免疫球蛋白在传染病的预防和治疗中的应用。
Infect Dis Clin North Am. 2011 Dec;25(4):773-88. doi: 10.1016/j.idc.2011.07.005.
3
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires.从多样化的 B 细胞库中生成重组超免疫球蛋白。
Nat Biotechnol. 2021 Aug;39(8):989-999. doi: 10.1038/s41587-021-00894-8. Epub 2021 Apr 15.
4
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者:快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
5
Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.人免疫球蛋白作为抗感染治疗的应用:迄今为止的经验及其可能再次出现的作用。
Expert Rev Anti Infect Ther. 2017 Jun;15(6):585-604. doi: 10.1080/14787210.2017.1328278. Epub 2017 May 15.
6
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.经鼻给药的超浓缩抗呼吸道合胞病毒免疫球蛋白:一种有前景的呼吸道合胞病毒预防方法。
Front Immunol. 2021 Jun 7;12:683902. doi: 10.3389/fimmu.2021.683902. eCollection 2021.
7
BERNA: a century of immunobiological innovation.伯纳:免疫生物学创新的一个世纪。
Vaccine. 1999 Oct 1;17 Suppl 2:S1-5. doi: 10.1016/s0264-410x(99)00228-5.
8
Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.从恢复期血浆中纯化静脉注射用严重急性呼吸综合征高效价免疫球蛋白。
Transfusion. 2005 Jul;45(7):1160-4. doi: 10.1111/j.1537-2995.2005.00179.x.
9
Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.高效价免疫球蛋白在呼吸道合胞病毒感染预防和治疗中的应用
Clin Microbiol Rev. 1995 Jan;8(1):22-33. doi: 10.1128/CMR.8.1.22.
10
Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma.源自康复期血浆的抗埃博拉病毒超免疫球蛋白的特性分析
J Infect Dis. 2022 Feb 15;225(4):733-740. doi: 10.1093/infdis/jiab432.

引用本文的文献

1
Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial.重组单克隆抗体siltartoxatug与血浆源性人破伤风免疫球蛋白治疗破伤风的比较:一项随机、双盲、活性对照的3期试验。
Nat Med. 2025 Jul 8. doi: 10.1038/s41591-025-03791-8.
2
Symptomatic central nervous system infections in kidney transplant recipients: a 20-years multicenter observational study.肾移植受者的症状性中枢神经系统感染:一项20年的多中心观察性研究。
BMC Infect Dis. 2025 May 1;25(1):641. doi: 10.1186/s12879-025-11039-6.
3
Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023).绘制到 2030 年全球 PID 进展的路线图——来自 IPOPI 全球利益相关者峰会的会议记录(2023 年 9 月)。
Front Immunol. 2024 Jun 27;15:1430678. doi: 10.3389/fimmu.2024.1430678. eCollection 2024.

本文引用的文献

1
Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.预防先天性巨细胞病毒感染:伐昔洛韦与免疫球蛋白治疗的综述和病例系列。
Viruses. 2023 Jun 15;15(6):1376. doi: 10.3390/v15061376.
2
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma.从 COVID-19 恢复期血浆中开发和表征抗 SARS-CoV-2 静脉用免疫球蛋白。
Immunotherapy. 2022 Oct;14(14):1133-1147. doi: 10.2217/imt-2022-0015. Epub 2022 Jul 27.
3
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies.奥密克戎 BA.1 和 BA.2 变异株对疫苗诱导的血清和治疗性单克隆抗体的耐药性。
Viruses. 2022 Jun 18;14(6):1334. doi: 10.3390/v14061334.
4
Rescue therapy with intravenous immunoglobulin in severe refractory dengue: A pilot study.静脉注射免疫球蛋白用于严重难治性登革热的挽救治疗:一项试点研究。
Med J Armed Forces India. 2022 Apr;78(2):204-212. doi: 10.1016/j.mjafi.2020.12.036. Epub 2021 Mar 26.
5
Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease.在基孔肯雅热感染和疾病的啮齿动物模型中,用病毒特异性抗体进行治疗性和预防性治疗非常有效。
Antiviral Res. 2022 Jun;202:105295. doi: 10.1016/j.antiviral.2022.105295. Epub 2022 Mar 24.
6
Lack of Evidence of Chikungunya Virus Infection among Blood Donors during the Chikungunya Outbreak in Lazio Region, Italy, 2017.2017 年意大利拉齐奥地区基孔肯雅热疫情期间献血者中无基孔肯雅病毒感染证据。
Viruses. 2022 Mar 16;14(3):619. doi: 10.3390/v14030619.
7
Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis.预防性人巨细胞病毒高效价免疫球蛋白在预防移植后巨细胞病毒感染中的有效性:一项系统评价和荟萃分析
Life (Basel). 2022 Mar 2;12(3):361. doi: 10.3390/life12030361.
8
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.SARS-CoV-2 奥密克戎亚谱系的抗体逃逸特性。
Nature. 2022 Apr;604(7906):553-556. doi: 10.1038/s41586-022-04594-4. Epub 2022 Mar 3.
9
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review.大剂量静脉注射多克隆免疫球蛋白治疗新型冠状病毒肺炎的疗效:一项系统评价
Vaccines (Basel). 2022 Jan 9;10(1):94. doi: 10.3390/vaccines10010094.
10
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.一种传染性 SARS-CoV-2 B.1.1.529 奥密克戎病毒能够逃避治疗性单克隆抗体的中和作用。
Nat Med. 2022 Mar;28(3):490-495. doi: 10.1038/s41591-021-01678-y. Epub 2022 Jan 19.